G-CSF for the prevention of mortality from severe melioidosis in Ubon Ratchathani, Thailand

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000024640

Enrollment

Registered

2005-07-19

Start date

2003-08-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Recruitment ongoing at Sappasithiprasong Hospital, Ubon Ratchathani, Thailand

Interventions

Study: Lenograstim 263mcg iv daily for 3 days

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

14 Years to No maximum

Healthy volunteers

Inclusion criteria

Severe sepsis (systemic inflammatory response syndrome and evidence of organ dysfunction) due to melioidosis suspected on clinical groups.

Exclusion criteria

Children <14 years, pregnancy, hypersensitivity to study drugs, haematological malignancy, febrile neutropenia.

Outcome results